文献速递皮肤肿瘤

黑色素瘤来源的可溶性DC-HIL/GPNMB通过将T淋巴细胞排除在转移前生态位外促进转移

Melanoma-Derived Soluble DC-HIL/GPNMB Promotes Metastasis by Excluding T-Lymphocytes from the Pre-Metastatic Niches.
PubMed 文献 · J Invest Dermatol · 2018-05-30

研究揭示黑色素瘤分泌的可溶性DC-HIL(sDC-HIL)与特定内皮细胞结合,赋予其T细胞抑制功能并诱导血管内皮生长因子表达,促进骨髓来源祖细胞和肿瘤细胞跨内皮迁移,但阻止T细胞迁移,从而形成转移前生态位并促进肺转移。

要点

  • sDC-HIL结合的内皮细胞在荷瘤与非荷瘤小鼠中频率相似,与静脉注射肿瘤细胞在肺内的存活强相关。
  • sDC-HIL结合使内皮细胞获得T细胞抑制功能并诱导血管内皮生长因子表达,增强骨髓祖细胞和肿瘤细胞跨内皮迁移,但不增强T细胞迁移。
  • 选择性源于sDC-HIL与T细胞结合,阻止趋化所需的前沿形成;诱导肿瘤表达sDC-HIL显著减少肿瘤浸润T细胞。

核心结论

  • B16黑色素瘤的高转移特性可由sDC-HIL的内皮门控功能解释,该功能限制淋巴细胞跨内皮迁移至转移前生态位。

研究设计与样本

  • 研究采用B16黑色素瘤模型,探究sDC-HIL的分子机制及其对转移前生态位形成的影响。

主要发现

  • sDC-HIL与特定内皮细胞结合,这些内皮细胞与骨髓来源祖细胞和肿瘤细胞迁移部位共定位。
  • sDC-HIL结合的内皮细胞在荷瘤与非荷瘤小鼠中频率相似,与静脉注射肿瘤细胞在肺内的存活强相关。
  • sDC-HIL结合赋予内皮细胞T细胞抑制功能,并通过诱导血管内皮生长因子表达唤醒血管生成特性,增强骨髓来源祖细胞和肿瘤细胞的跨内皮迁移,但不增强T细胞迁移。
  • 选择性由sDC-HIL与T细胞结合实现,阻止趋化所需的前沿形成。
  • 诱导肿瘤表达sDC-HIL显著减少肿瘤浸润T细胞。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Soluble factors from the primary tumor induce recruitment of bone marrow-derived progenitors to form tumor-supportive microenvironments or pre-metastatic niches in distal organs before metastasis. How tumor-secreted factors condition the sites for tumor progression remains ambiguous. B16 melanoma produces the secreted form of T cell-inhibitory DC-HIL (sDC-HIL) that travels to distal organs and potentiates the metastatic capacity of tumor cells. We studied the molecular mechanisms and found that sDC-HIL binds to select endothelial cells that co-localize with the sites where bone marrow-derived progenitors and tumor cells migrate. sDC-HIL-bound endothelial cells exist at a similar frequency in mice with or without tumors, and they are strongly associated with survival of intravenously injected tumor cells in the lung. sDC-HIL binding conferred T-cell suppressor function on the ECs and awakened the angiogenic property by inducing vascular endothelial growth factor expression, resulting in enhanced transendothelial migration of bone marrow-derived progenitors and tumor cells, but not for T cells. This selectivity is achieved by the T-cell binding of sDC-HIL, which prevents formation of the leading edges required for chemotaxis. Finally, inducing tumor expression of sDC-HIL significantly reduced tumor-infiltrated T cells. Therefore, the highly metastatic attribute of B16 melanoma can be explained by the endothelial gatekeeper function of sDC-HIL that limits lymphocyte transmigration to pre-metastatic niches.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Ramani V, Teshima T, Tamura K, et al. Melanoma-Derived Soluble DC-HIL/GPNMB Promotes Metastasis by Excluding T-Lymphocytes from the Pre-Metastatic Niches. J Invest Dermatol. 2018. PMID: 29857071. doi:10.1016/j.jid.2018.05.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。